Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Mads Damsgaard has worked on the following 4 EPO patent applications which have been published in the last five years:

EP13815781

AMINOPYRIDINE DERIVED COMPOUNDS AS LRRK2 INHIBITORS

IPC classification:
A61K 31/4439, A61K 31/444, A61K 31/497, A61P 25/16, A61P 35/00, C07D 401/04, C07D 401/14, C07D 403/14, C07D 413/04, C07D 413/14
Applicant:
H. Lundbeck A/S
Agent:
Mads Damsgaard, H. Lundbeck A/S
Status:
The patent has been granted
EP14702497

N-SUBSTITUTED-5-SUBSTITUTED PHTHALAMIC ACIDS AS SORTILIN INHIBITORS

IPC classification:
A61K 31/44, A61K 31/4402, A61K 31/4406, A61P 25/00, C07D 213/60, C07D 213/65, C07D 401/04, C07D 403/04, C07D 417/04
Applicant:
H. Lundbeck A/S
Agent:
Mads Damsgaard, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED
EP14720062

ARYLPYRROLOPYRIDINE DERIVED COMPOUNDS AS LRRK2 INHIBITORS

IPC classification:
A61K 31/437, A61P 25/00, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
H. Lundbeck A/S
Agent:
Mads Damsgaard, H. Lundbeck A/S
Status:
The patent has been granted
EP11725865

MODULATION OF THE INTERACTION BETWEEN SORLA AND GDNF-FAMILY LIGAND RECEPTORS

IPC classification:
A61K 38/00, A61K 38/18, C07K 16/28
Applicant:
H. Lundbeck A/S
Agent:
Mads Damsgaard, H. Lundbeck A/S
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature